Work

Abstract CT048: A first in human, dose escalation (DE) and biomarker cohort expansion (BCE) of IMT-009 (IMT) in advanced cancer and Phase 1b (Ph1b) combination with fruquintinib (F) in microsatellite stable colorectal cancer (MSS CRC)

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct048

Authors: Susanna V. Ulahannan, Melissa Johnson, Jason T. Henry, Shruti Malu, Sudhir Manda, Manish R. Patel, Shivaani Kummar, Adwitiya Kar, Alexander Spira, Vivian Cline, Ana L. Costa, Sarah Djeddi, Diane Stebbins, Nicholas Ferenc, Lucy Chen, James E. Wooldridge, Cesar A. Perez

Institutions: OU Health Stephenson Cancer Center, Sarah Cannon, HealthONE, Tucson Medical Center, Florida Cancer Specialists & Research Institute, Oregon Health & Science University, Texas Oncology, Takeda (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154723155

Cites:

Cited by:

Related to: